Experienced in Lung Metastases

Kjersti Flatmark

Oslo, NO 
Experienced in Lung Metastases
Oslo, NO 
OverviewLocationsClinical Research

Overview

Kjersti Flatmark practices in Oslo, Norway. Ms. Flatmark is rated as an Experienced expert by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Pseudomyxoma Peritonei, Colorectal Cancer, Cerebral Hypoxia, Hepato-Pancreato-Biliary Surgery, and Hepatectomy.

Her clinical research consists of co-authoring 126 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Lung Metastases.

Gender
Female

Locations

Oslo, Norway
Other Locations
Nydalen, 0424, Norway
Blindern, 0318, Norway

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin
METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin
Enrollment Status: Active_not_recruiting
Publish Date: January 30, 2024
Intervention Type: Drug
Study Phase: Phase 2
Computer Navigation-assisted Surgery for Locally Advanced and Recurrent Rectal Cancer
Computer Navigation-assisted Surgery for Locally Advanced and Recurrent Rectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 14, 2022
Intervention Type: Device
Study Phase: Not Applicable
Prospective Observational Study of Exfoliated Peritoneal Tumor Cells in Locally Advanced Rectal Cancer
Prospective Observational Study of Exfoliated Peritoneal Tumor Cells in Locally Advanced Rectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2021
Intervention Type: Other
Phase I/II Trial of MOC31PE Immunotoxin in Peritoneal Carcinomatosis From Colorectal Carcinoma
Phase I/II Trial of MOC31PE Immunotoxin in Peritoneal Carcinomatosis From Colorectal Carcinoma
Enrollment Status: Completed
Publish Date: May 30, 2017
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

126 Total Publications

ASO Visual Abstract: Intraperitoneal Perfusion with Cisplatin or Mitomycin C Improves Survival in Mice Bearing Peritoneal Metastases from Ovarian Cancer.
ASO Visual Abstract: Intraperitoneal Perfusion with Cisplatin or Mitomycin C Improves Survival in Mice Bearing Peritoneal Metastases from Ovarian Cancer.
Journal: Annals of surgical oncology
Published: October 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Flatmark's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile